4.49
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
21.51%
4.044
|
3.328 | 3.633 | 3.103 | 3.643 |
| Operating Income/Loss |
22.23%
-7.61
|
-6.226 | -6.48 | -5.213 | -6.024 |
| Income/Loss From Continuing Operations Before Tax |
21.68%
-7.549
|
-6.204 | -6.408 | -5.101 | -5.883 |
| Income/Loss From Continuing Operations After Tax |
21.68%
-7.549
|
-6.204 | -6.408 | -5.101 | -5.883 |
|
|
21.68%
-7.549
|
-6.204 | -6.408 | -5.101 | -5.883 |
| Preferred Stock Dividends And Other Adjustments |
1.479
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
448.54%
4.049
|
0.7381 | 1.4585 | 10.55 | 3.5199 |
| Diluted Average Shares |
448.54%
4.049
|
0.7381 | 1.4585 | 10.55 | 3.5199 |
| Basic Earnings Per Share |
73.45%
-2.23
|
-8.40 | -4.39 | -0.48 | -1.67 |
| Diluted Earnings Per Share |
73.45%
-2.23
|
-8.40 | -4.39 | -0.48 | -1.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
1.479
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):